Structure and aggregation mechanisms in amyloids
ZL Almeida, RMM Brito - Molecules, 2020 - mdpi.com
The aggregation of a polypeptide chain into amyloid fibrils and their accumulation and
deposition into insoluble plaques and intracellular inclusions is the hallmark of several …
deposition into insoluble plaques and intracellular inclusions is the hallmark of several …
Protofibrils of amyloid-β are important targets of a disease-modifying approach for Alzheimer's disease
K Ono, M Tsuji - International journal of molecular sciences, 2020 - mdpi.com
Worldwide, Alzheimer's disease (AD) is the most common age-related neurodegenerative
disease and is characterized by unique pathological hallmarks in the brain, including …
disease and is characterized by unique pathological hallmarks in the brain, including …
High-speed atomic force microscopy reveals the structural dynamics of the amyloid-β and amylin aggregation pathways
T Watanabe-Nakayama, BR Sahoo… - International journal of …, 2020 - mdpi.com
Individual Alzheimer's disease (AD) patients have been shown to have structurally distinct
amyloid-β (Aβ) aggregates, including fibrils, in their brain. These findings suggest the …
amyloid-β (Aβ) aggregates, including fibrils, in their brain. These findings suggest the …
MIRRAGGE–minimum information required for reproducible AGGregation experiments
Reports on phase separation and amyloid formation for multiple proteins and aggregation-
prone peptides are recurrently used to explore the molecular mechanisms associated with …
prone peptides are recurrently used to explore the molecular mechanisms associated with …
Inhibitor and substrate cooperate to inhibit amyloid fibril elongation of α-synuclein
ED Agerschou, V Borgmann, MM Wördehoff… - Chemical …, 2020 - pubs.rsc.org
In amyloid fibril elongation, soluble growth substrate binds to the fibril-end and converts into
the fibril conformation. This process is targeted by inhibitors that block fibril-ends. Here, we …
the fibril conformation. This process is targeted by inhibitors that block fibril-ends. Here, we …
Time-resolved observation of evolution of amyloid-β oligomer with temporary salt crystals
The aggregation behavior of amyloid-β (Aβ) peptides remains unclarified despite the fact
that it is closely related to the pathogenic mechanism of Alzheimer's disease. Aβ peptides …
that it is closely related to the pathogenic mechanism of Alzheimer's disease. Aβ peptides …
Network Hamiltonian models reveal pathways to amyloid fibril formation
Amyloid fibril formation is central to the etiology of a wide range of serious human diseases,
such as Alzheimer's disease and prion diseases. Despite an ever growing collection of …
such as Alzheimer's disease and prion diseases. Despite an ever growing collection of …
Enhanced self-assembly of the 7–12 sequence of amyloid-β peptide by tyrosine bromination
Alzheimer's disease (AD) is a serious neuropathology related to the misfolded assembly
state of amyloid-beta (Aβ40 and Aβ42) peptides. It has been demonstrated that protein post …
state of amyloid-beta (Aβ40 and Aβ42) peptides. It has been demonstrated that protein post …
Halogenation of the N‐Terminus Tyrosine 10 Promotes Supramolecular Stabilization of the Amyloid‐β Sequence 7–12
Here, we demonstrate that introduction of halogen atoms at the tyrosine 10 phenol ring of
the DSGYEV sequence derived from the flexible amyloid‐β N‐terminus, promotes its self …
the DSGYEV sequence derived from the flexible amyloid‐β N‐terminus, promotes its self …
Molecular mechanisms of amyloid aggregation in human proteinopathies
B Morel, F Conejero-Lara - Protein Homeostasis Diseases, 2020 - Elsevier
An increasing number of human disorders has been identified as associated to or directly
caused by aberrant protein aggregation and especially amyloid fibril formation. In this …
caused by aberrant protein aggregation and especially amyloid fibril formation. In this …